Saltar al contenido
Merck

O4386

L-Ornithine monohydrochloride

≥99%, BioXtra

Sinónimos:

(S)-2,5-Diaminopentanoic acid monohydrochloride

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

Fórmula empírica (notación de Hill):
C5H12N2O2 · HCl
Número CAS:
Peso molecular:
168.62
NACRES:
NA.26
PubChem Substance ID:
UNSPSC Code:
12352209
EC Number:
221-678-6
MDL number:
Beilstein/REAXYS Number:
3625847
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


Nombre del producto

L-Ornithine monohydrochloride, BioXtra, ≥99%

product line

BioXtra

Quality Level

assay

≥99%

form

powder

impurities

ammonia- and citrulline-free, essentially free, ≤0.005% Phosphorus (P), ≤0.1% Insoluble matter

ign. residue

≤0.1%

color

white

solubility

H2O: 1 M at 20 °C, clear, faintly yellow

anion traces

sulfate (SO42-): ≤0.05%

cation traces

Al: ≤0.0005%, Ca: ≤0.005%, Cu: ≤0.0005%, Fe: ≤0.0005%, K: ≤0.005%, Mg: ≤0.0005%, NH4+: ≤0.05%, Na: ≤0.005%, Pb: ≤0.001%, Zn: ≤0.0005%

SMILES string

Cl.NCCC[C@H](N)C(O)=O

InChI

1S/C5H12N2O2.ClH/c6-3-1-2-4(7)5(8)9;/h4H,1-3,6-7H2,(H,8,9);1H/t4-;/m0./s1

InChI key

GGTYBZJRPHEQDG-WCCKRBBISA-N

Biochem/physiol Actions

L-Ornithine is a not encoded by DNA. It is a free amino acid but do not participate in the protein synthesis. It is formed by the action of the enzyme arginase on L-arginine in the process of forming urea. It is implicated in the reduction of blood ammonia level and improves the efficiency of energy production to cause ammonia detoxification. L-ornithine promotes the release of growth hormone by triggering the pituitary gland.

Other Notes

Product of arginine degradation by arginase


Still not finding the right product?

Explore all of our products under


Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism
Sugino T, et al.
Nutrition Research (New York, N.Y.), 28(11), 738-743 (2008)
The effect of L-ornithine hydrochloride ingestion on performance during incremental exhaustive ergometer bicycle exercise and ammonia metabolism during and after exercise
Demura S, et al.
European Journal of Clinical Nutrition, 64(10), 1166-1171 (2010)
Sherry Dadsetan et al.
Biochemical pharmacology, 85(1), 115-123 (2012-10-30)
Combined administration of ornithine and phenylacetate (OP) is proposed as a novel treatment of hyperammonemia and hepatic encephalopathy. Ornithine is believed to increase ammonia fixation into glutamine in muscle tissue and glutamine is subsequently thought to react with phenylacetate forming